ASAP Semiconductor appreciates your request for quotation sent via JetParts360.com for part number NDC00006-4981-00 made by Manufacturer Merck Sharp And Dohme Corp with it's corresponding NSN 6505014753038, CAGE Code 06990 and FSC . This NDC00006-4981-00 part is described as Hepatitis B Virus Vaccine Inacti. You can expect a response from a dedicated customer service expert from ASAP Semiconductor within 15 minutes. Each RFQ is answered in the order it was received. We request you to fill out your contact information, as well as quantity, and any target price along with an expected delivery date for NDC00006-4981-00 part. We will strive to provide you with an aggressive price to earn the opportunity for your business.
Please Fill Out Below Form
“*” Symbols for mandatory fields
You can mail your Bill of Materials (BOM) to sales@jetparts360.com. Please do not hesitate to contact us if you have any additional questions. With over 50,000 manufacturers and 20 million unique part numbers we are a one stop shop for all aerospace and aviation requirements. Feel free to browse our website, JetParts360.com for any additional parts that you might require or download the ASAP Semiconductor App on the Google Play store. We are available 24/7 at +1-714-705-4780.
6505-01-475-3038, 6505014753038 Characteristics Data
MRC
Criteria
Characteristic
AGXZ
UNIT PACKAGE TYPE
PACKAGE
AJCN
PROTECTIVE STORAGE FEATURE
REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C AND SUBJECT TO DAMAGE BY FREEZING
ANNW
III IMMEDIATE CONTAINER TYPE
VIAL, SINGLE DOSE
ANNX
IMMEDIATE CONTAINER QUANTITY
10
ANNY
QUANTITY WITHIN EACH IMMEDIATE CONTAINER
10DOSES AND 5MCG/0.5ML VIALS
CXCY
PART NAME ASSIGNED BY CONTROLLING AGENCY
HEPATITIS B VIRUS VACCINE INACTIVATED MODIFIED SGL DOSE VIAL 10S
FEAT
SPECIAL FEATURES
VACCINE PRESERVATIVE FREE AND THIMEROSAL FREE;RECOMBIVAX HB (RECOMBINANT) IS FOR INTRAMUSCULAR INJECTION; FOR USE IN INFANTS, CHILDREN AND ADOLESCENTS (AGES 0-19); DOSAGE SUPPLIED AS 5 MCG/0.5 ML OF HBSAG (SURFACE ANTIGEN) IN A 0.5 ML SINGL
SUPP
SUPPLEMENTARY FEATURES
ARECOMMENDED VACCINATION REGIMENS CONSISTS OF 3 DOSES AT 5MCG EACH; TO BE ADMINISTERED AS FOLLOWS: FIRST DOSE AT ELECTED DATE; SECOND DOSE 1 MONTH LATER; THIRD DOSE 6 MONTHS AFTER THE FIRST DOSE
We use cookies to ensure that we give you the great experience on our website. If you continue to use this site we will assume that you are happy with it.